*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Over the last two years, a group of researchers at Georgia Tech, Emory University, and Children's Healthcare of Atlanta has played a key, but largely hidden, role in
getting Covid tests into the hands of Americans, working with the National Institutes of Health and the Food and Drug Administration. “We kind of functioned as their eyes and hands to answer the question, Do these tests work?” said Wilbur Lam, professor in the Parker H. Petit Institute for Bioengineering and Bioscience (IBB). “Essentially, we’re testing the tests.” College of Sciences contributors to the Georgia Tech/Emory/CHOA collaboration include Greg Gibson, Regents Professor, Tom and Marie Patton Chair in the School of Biological Sciences, Director of the Center for Integrative Genomics, and IBB member; Steve Woodward, senior assistant director, core facilities, IBB; and Andrés Garcia, IBB executive director. Georgia Tech Surveillance Testing also participated in sample collection and sequencing.
